Brigatinib is a targeted therapy medication primarily used to treat nonsmall cell lung cancer (NSCLC) that has a specific genetic mutation known as ALK (anaplastic lymphoma kinase). It is designed for patients whose cancer has progressed after treatment with another ALK inhibitor. Brigatinib works by blocking the signals that promote cancer cell growth, thereby helping to slow down or stop the progression of the disease.
Brexpiprazole is an atypical antipsychotic medication primarily used to treat mental health conditions such as schizophrenia and major depressive disorder (MDD). Approved by the FDA in 2015, it is designed to help manage symptoms associated with these disorders, improving the quality of life for those affected. Brexpiprazole works by balancing certain chemicals in the brain, which can help alleviate symptoms like hallucinations, delusions, and mood disturbances.
Bretylium is a medication primarily used in emergency medicine, particularly for the treatment of certain types of lifethreatening arrhythmias, such as ventricular fibrillation and ventricular tachycardia. It belongs to a class of drugs known as antiarrhythmics, which help to stabilize the heart's rhythm. Bretylium is often administered in hospital settings, especially during cardiac emergencies, to restore normal heart function.
Bretylium is approved for several medical uses, including:
Bosutinib is a targeted therapy medication primarily used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins that promote cancer cell growth. By inhibiting these proteins, Bosutinib helps to slow down or stop the progression of the disease, making it a vital option for patients with CML, especially those who have not responded to other treatments.
Bosentan is an oral medication designed to block the action of endothelin, a natural substance in the body that narrows blood vessels. By inhibiting endothelin, Bosentan helps to relax blood vessels, improving blood flow and reducing strain on the heart and lungs.
Bortezomib is a pivotal medication in the landscape of oncology, particularly known for its effectiveness in treating multiple myeloma and mantle cell lymphoma. As an inhibitor of the 26S proteasome in cells, bortezomib disrupts various cell signaling pathways, which leads to cancer cell death and inhibits tumor growth. This guide delves into the uses, dosage, side effects, and other essential information about bortezomib, offering a comprehensive overview for those seeking to understand more about this chemotherapy drug.
Blinatumomab is a bispecific CD19-directed CD3 T-cell engager, which belongs to a class of drugs known as bispecific T-cell engagers (BiTEs). This medication is uniquely designed to connect CD3-positive cytotoxic T cells to CD19-positive B cells, leading to the destruction of malignant B cells. Primarily, it is utilized in the treatment of acute lymphoblastic leukemia (ALL), a type of cancer that affects the white blood cells.
Blinatumomab is approved for the treatment of:
Bleomycin is an anticancer medication used to treat various types of cancer by interfering with the growth and replication of cancer cells. This guide provides a detailed overview of its uses, dosage, side effects, interactions, and benefits.
Bleomycin is a chemotherapy drug classified as an antitumor antibiotic. It works by binding to DNA and causing breaks, leading to the inhibition of cancer cell growth and division. It is typically used in combination with other chemotherapy agents.
Bivalirudin is a direct thrombin inhibitor primarily used as an anticoagulant during certain cardiovascular procedures. This guide provides an indepth overview of its uses, dosage, side effects, interactions, and benefits.
Bivalirudin is a synthetic peptidebased anticoagulant that works by directly inhibiting thrombin, an enzyme essential for blood clot formation. It is most commonly used in patients undergoing percutaneous coronary intervention (PCI) and other cardiac procedures.
Bismuth subsalicylate is an over-the-counter medication widely used for digestive issues such as diarrhea, indigestion, and nausea. This guide provides a comprehensive overview of its uses, dosage, side effects, interactions, and benefits.
Bismuth subsalicylate is a compound that has antidiarrheal, anti-inflammatory, and antibacterial properties. It works by coating the stomach lining, reducing inflammation, and binding toxins in the gastrointestinal tract. It is commonly available under brand names like PeptoBismol and Kaopectate.
